UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 0.7% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,549,015 shares of the medical device company's stock after purchasing an additional 18,946 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 1.31% of Cooper Companies worth $182,790,000 at the end of the most recent reporting period.
Other hedge funds have also recently added to or reduced their stakes in the company. Avalon Trust Co acquired a new stake in shares of Cooper Companies during the second quarter worth $25,000. Root Financial Partners LLC grew its position in shares of Cooper Companies by 104.5% during the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company's stock valued at $26,000 after buying an additional 162 shares during the last quarter. SJS Investment Consulting Inc. raised its stake in Cooper Companies by 107.5% during the first quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company's stock worth $26,000 after acquiring an additional 187 shares during the period. Elevation Wealth Partners LLC lifted its holdings in Cooper Companies by 1,136.4% in the second quarter. Elevation Wealth Partners LLC now owns 408 shares of the medical device company's stock worth $29,000 after acquiring an additional 375 shares during the last quarter. Finally, J.Safra Asset Management Corp acquired a new position in Cooper Companies in the second quarter valued at approximately $32,000. Institutional investors and hedge funds own 24.39% of the company's stock.
Wall Street Analyst Weigh In
A number of analysts have recently weighed in on COO shares. Needham & Company LLC dropped their price target on Cooper Companies from $101.00 to $86.00 and set a "buy" rating on the stock in a research report on Friday, June 5th. JPMorgan Chase & Co. reduced their price objective on Cooper Companies from $80.00 to $71.00 and set a "neutral" rating for the company in a research report on Friday, June 5th. Mizuho set a $85.00 price objective on Cooper Companies and gave the stock an "outperform" rating in a research note on Thursday, June 4th. KeyCorp reiterated a "sector weight" rating on shares of Cooper Companies in a research note on Friday, June 5th. Finally, Wall Street Zen raised shares of Cooper Companies from a "hold" rating to a "buy" rating in a report on Sunday, June 21st. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Hold" and a consensus target price of $81.64.
View Our Latest Stock Analysis on COO
Cooper Companies Stock Performance
COO opened at $69.28 on Wednesday. The company has a current ratio of 1.27, a quick ratio of 0.78 and a debt-to-equity ratio of 0.23. The business's 50 day moving average is $72.72 and its 200-day moving average is $70.63. The stock has a market cap of $13.51 billion, a PE ratio of 58.71, a price-to-earnings-growth ratio of 1.83 and a beta of 0.82. The Cooper Companies, Inc. has a twelve month low of $58.89 and a twelve month high of $89.83.
Cooper Companies (NASDAQ:COO - Get Free Report) last posted its earnings results on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, beating the consensus estimate of $1.10 by $0.11. The firm had revenue of $1.08 billion for the quarter, compared to analysts' expectations of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The firm's revenue was up 7.9% compared to the same quarter last year. During the same period last year, the firm earned $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, analysts predict that The Cooper Companies, Inc. will post 4.63 earnings per share for the current year.
Cooper Companies Profile
(
Free Report)
Cooper Companies, Inc NASDAQ: COO is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women's health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.
The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Cooper Companies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cooper Companies wasn't on the list.
While Cooper Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
